For pharmacists, from Drug Topics: Articles, features, and news briefs for pharmacists about drugs and drug trials, professional trends, and legal changes in the pharmacy industry
November 3, 2009
By:Drug Topics staff
Schnucks Markets plans to get customers into its pharmacy departments with the addition of EyeSite vision-screening kiosks. Thirty kiosks were recently added to its grocery stores in the St. Louis area.
 |
November 3, 2009
By:Bruce T. Roberts, RPh
In the prescription drug market, discriminatory pricing is common for independent community pharmacies and their patients. This fall, a Federal District Court in New York will consider a critical case: Drug Mart Pharmacy Corp. et a. v. American Home Products Corp. et al. The outcome of the case may determine whether discriminatory pricing techniques are illegal.
|
November 3, 2009
By:Drug Topics staff
With the subject of healthcare reform on the front burner in Washington and across the country, Drug Topics invited members of its Frontline editorial advisory board to share their thoughts. A selection of their responses is presented here.
|
November 3, 2009
By:Eric Durbin, RPh
Instead of giving out cards that reduce the copay of a prescription, why not just decrease the price per bottle of medication?
|
November 3, 2009
By:Drug Topics staff
Barnes-Jewish Hospital, Express Scripts Inc., and The St. Louis College of Pharmacy are giving 35 high school students their first look at pharmacy careers in the BESt Summer Pharmacy Institute program.
|
October 9, 2009
By:Alaina Scott, Senior Editor
A second round of revised quality standards for heparin became effective recently, the U.S. Pharmacopeial (USP) Convention has announced.
|
October 8, 2009
By:Martin Sipkoff
When manufacture of biogenerics is a legal reality, brand manufacturers will still retain a strong market share for several years.
|
October 8, 2009
By:Alaina Scott, Senior Editor
The FDA has announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies.
|
October 8, 2009
By:Raichell S. Brown, PharmD, JD
The FDA recently alerted pharmacists to medication error reports about mefloquine (Lariam) prescriptions calling for 250 mg daily rather than the recommended dose of 250 mg weekly for malaria prophylaxis.
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| Is knowledge of herbal supplements valuable to you in the practice of pharmacy? | | | No, not at all. | | 0% | | | Yes, somewhat. | | 30% | | | Definitely helpful. | | 52% | | | It comes up daily. | | 17% | |
| | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
